Giulia Stazi

898 total citations
16 papers, 517 citations indexed

About

Giulia Stazi is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Giulia Stazi has authored 16 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Giulia Stazi's work include Epigenetics and DNA Methylation (12 papers), Histone Deacetylase Inhibitors Research (8 papers) and Protein Degradation and Inhibitors (5 papers). Giulia Stazi is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Histone Deacetylase Inhibitors Research (8 papers) and Protein Degradation and Inhibitors (5 papers). Giulia Stazi collaborates with scholars based in Italy, France and United States. Giulia Stazi's co-authors include Antonello Mai, Sérgio Valente, Clemens Zwergel, Rossella Fioravanti, Andrea Mattevi, Biagina Marrocco, Paola Vianello, Saverio Minucci, Oronza A. Botrugno and Ciro Mercurio and has published in prestigious journals such as Philosophical Transactions of the Royal Society B Biological Sciences, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Giulia Stazi

16 papers receiving 516 citations

Peers

Giulia Stazi

GENET

ONCOL

Shinya Mimasu Japan

Cordelle Tanega United States

Christina Gros France

Katherine S. England United Kingdom

Ramzi H. Abbassi Australia

Agnieszka Gnyszka Poland

Aya Kurosawa Japan

Mauro Ponti Italy

Frances Potjewyd United States

Roberto Dal Zuffo Italy

Shinya Mimasu Japan

Giulia Stazi

455 ×1.1

48 ×0.6

40 ×0.7

GENET

37 ×0.7

31 ×0.6

ONCOL

Citations per year, relative to Giulia Stazi Giulia Stazi (= 1×) peers Shinya Mimasu

Countries citing papers authored by Giulia Stazi

Since Specialization

Citations

This map shows the geographic impact of Giulia Stazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Stazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Stazi more than expected).

Fields of papers citing papers by Giulia Stazi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Stazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Stazi. The network helps show where Giulia Stazi may publish in the future.

Co-authorship network of co-authors of Giulia Stazi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Stazi. A scholar is included among the top collaborators of Giulia Stazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Stazi. Giulia Stazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stazi, Giulia, Rossella Fioravanti, Clemens Zwergel, et al.. (2020). Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells. ACS Medicinal Chemistry Letters. 11(5). 977–983. 59 indexed citations

Zwergel, Clemens, Rossella Fioravanti, Giulia Stazi, et al.. (2020). Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers. 12(2). 447–447. 6 indexed citations

Lanni, Stella, Alberto Vitali, Massimo Castagnola, et al.. (2020). Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene. Human Genetics. 139(2). 227–245. 18 indexed citations

Stazi, Giulia, Rossella Fioravanti, Antonello Mai, Andrea Mattevi, & Sérgio Valente. (2019). Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer. Current Opinion in Chemical Biology. 50. 89–100. 27 indexed citations

Manara, Maria Cristina, Sérgio Valente, Giordano Nicoletti, et al.. (2018). A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy. Molecular Cancer Therapeutics. 17(9). 1881–1892. 38 indexed citations

Mellini, Paolo, Biagina Marrocco, Lucia Polletta, et al.. (2018). Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells. Philosophical Transactions of the Royal Society B Biological Sciences. 373(1748). 20170150–20170150. 18 indexed citations

Zwergel, Clemens, Giulia Stazi, Zein Mersini Besharat, et al.. (2018). Application of Small Epigenetic Modulators in Pediatric Medulloblastoma. Frontiers in Pediatrics. 6. 370–370. 13 indexed citations

Fioravanti, Rossella, Giulia Stazi, Clemens Zwergel, Sérgio Valente, & Antonello Mai. (2018). Six Years (2012–2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2‐Pyridone Compounds. The Chemical Record. 18(12). 1818–1832. 91 indexed citations

Stazi, Giulia, Clemens Zwergel, Antonello Mai, & Sérgio Valente. (2017). EZH2 inhibitors: a patent review (2014-2016). Expert Opinion on Therapeutic Patents. 27(7). 797–813. 36 indexed citations

10.

Zwergel, Clemens, Giulia Stazi, Mattia Mori, et al.. (2017). Novel coumarin- and quinolinone-based polycycles as cell division cycle 25-A and -C phosphatases inhibitors induce proliferation arrest and apoptosis in cancer cells. European Journal of Medicinal Chemistry. 134. 316–333. 24 indexed citations

11.

Miele, Evelina, Sérgio Valente, Vincenzo Alfano, et al.. (2017). The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells. Oncotarget. 8(40). 68557–68570. 36 indexed citations

12.

Zwergel, Clemens, Giulia Stazi, Sérgio Valente, & Antonello Mai. (2016). Histone Deacetylase Inhibitors: Updated Studies in Various Epigenetic-Related Diseases. 2(1). 26 indexed citations

13.

Stazi, Giulia, Clemens Zwergel, Sérgio Valente, & Antonello Mai. (2016). LSD1 inhibitors: a patent review (2010-2015). Expert Opinion on Therapeutic Patents. 26(5). 565–580. 44 indexed citations

14.

Vianello, Paola, Oronza A. Botrugno, Roberto Dal Zuffo, et al.. (2015). Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent. Journal of Medicinal Chemistry. 59(4). 1501–1517. 58 indexed citations

15.

Rodríguez, Verónica M., Sérgio Valente, S. Rovida, et al.. (2014). Pyrrole- and indole-containing tranylcypromine derivatives as novel lysine-specific demethylase 1 inhibitors active on cancer cells. MedChemComm. 6(4). 665–670. 21 indexed citations

16.

Stazi, Giulia, et al.. (1987). [Creatine phosphate: an additive to cardioplegic solutions. Clinical study].. PubMed. 32(3). 307–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact